54
Views
18
CrossRef citations to date
0
Altmetric
Original

A COMPARISON OF HIV RISK BEHAVIORS BETWEEN NEW AND LONG-TERM INJECTION DRUG USERS

, Ph.D., , M.S.P.H., , Ph.D., , Ph.D. & , M.A.
Pages 91-111 | Published online: 31 Jan 2001

REFERENCES

  • Kinlock T. W., Hanlon T. E., Nurco D. N. Heroin Use in the United States: History and Present Developments. Heroin in the Age of Crack-Cocaine, J. A. Inciardi, L. D. Harrison. Sage Publications, Inc., Thousand Oaks, CA 1998; 1–30
  • Handbook on Risk of AIDS, B. S. Brown, G. M. Beshner. Greenwood Press, Westport, CT 1993
  • Moss A. R. AIDS and Intravenous Drug Use: The Real Heterosexual Epidemic. Br. Med. J. 1987; 294: 389–390
  • Robert-Guroff M., Weiss S. H., Giron J. A., Jennings A. M., Ginzburg H. M., Margolis I. B., Blättner W. A., Gallo R. C. Prevalence of Antibodies of HTLV-I, -II, and III in Intravenous Drug Abusers from an AIDS Endemic Region. JAMA 1986; 255: 3133–3137
  • D'Aquila R., Williams A. B., Kleber H. D., Williams A. E. Prevalence of HTLV-III Infection among New Haven, Connecticut, Parenteral Drug Abusers in 1982–1983. N. Engl. J. Med. 1986; 314: 117–118
  • Ginzburg H. M., Weiss S. H., MacDonald M. G., Hubbard R. L. HTLV-III Exposure among Drug Users. Cancer Res. 1985; 45(Suppl)4605s–4608s
  • Marmor M., Des Jarlais D. C., Cohen H., Friedman S. R., Beatrice S. T., El-Sadr W., Mildvan D., Yancovitz S., Mathur U., Holzman R. Risk Factors for Infection with Human Immunodeficiency Virus among Intravenous Drug Abusers in New York City. AIDS 1987; 1: 39–44
  • D'Aquila R. T., Peterson L. R., Williams A. B., Williams A. E. Race/Ethnicity as a Risk Factor for HIV-1 Infection among Connecticut Intravenous Drug Users. J. AIDS 1989; 2: 503–513
  • Van Ameijden E. J., Van Den Hoek J. A.R., Hartgers C., Coutinho R. A. Risk Factors for the Transition From Noninjection to Injection Drug Use and Accompanying AIDS Risk Behavior in a Cohort of Drug Users. Am. J. Epidemiol. 1994; 139: 1153–1163
  • Zeldis J. B., Kuramoto K., Richards C., Sazama K., Samuels S., Holland P. V., Flynn N. Serepidemiology of Viral Infections among Intravenous Drug Users in Northern California. West J. Med. 1992; 156: 30–35
  • Chitwood D. D., Griffin D. K., Comerford M., Page J. B., Trapido E. J., Shenghan L. M.C.B. Risk Factors for HIV-1 Seroconversion among Injection Drug Users: A Case-Control Study. Am. J. Public Health 1995; 85: 1538–1542
  • Schoenbaum E. E., Hartel D., Selwyn P. A., Klein R. S., Davenny K., Rogers M., Feiner C., Friedland G. Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug Users. N. Engl. J. Med. 1989; 321: 874–879
  • Vlahov D., Munoz A., Anthony J. C., Cohn S., Celentano D. D., Nelson K. E. Association of Drug Injection Patterns with Antibody to Human Immunodeficiency Virus Type 1 among Intravenous Drug Users in Baltimore, Maryland. Am. J. Epidemiol. 1990; 132: 847–856
  • Alcabes P., Vlahov D., Anthony J. C. Correlates of Human Immunodeficiency Virus Infection in Intravenous Drug Users: Are Treatment Program Samples Misleading?. Br. J. Addict. 1992; 87: 47–54
  • Williams M. L. HIV seroprevalence among male IVDUs in Houston, Texas. Am J. Public Health 1990; 80: 1507–1509
  • Chitwood D. D., McCoy C. B., Comerford M., Kitner K. The Prevalence and Incidence of HIV among Injection Drug Users: A Five Year Panel Study. Popul. Res. Pol. Rev. 1999; 18: 39–53
  • Battjes R. J., Pickens R. W., Haverkos H. W., Sloboda Z. HIV Risk Factors among Injecting Drug Users in Five US Cities. AIDS 1994; 8: 681–687
  • Raymond C. A. Study of IV Drug Users and AIDS Finds Differing Infection Rate, Risk Behaviors. JAMA 1988; 260: 3105–3105
  • Gibson D. R., McCusker J., Chesney M. Effectiveness of Psychosocial Interventions in Preventing HIV Risk Behaviour in Injecting Drug Users. AIDS 1998; 12: 919–929
  • Bonito A. J., Bohlig E. M., Dennis M. L., Fairbank J. A., Rachal J. V. A Comparison of AIDS Intervention Approaches for Injection Drug Users: Street Outreach Versus Drug Treatment Intake—Are They Hitting the Same or Different Targets?. Handbook on Risk of AIDS, B. S. Brown, G. M. Beschner. Greenwood Press, Westport, CT 1993; 396–434
  • Friedman S. R., Neaigus A., Des Jarlais D. C., Sotheran J. L., Woods J., Sufian M., Stepherson B., Sterk C. Social Intervention Against AIDS among Injecting Drug Users. Br. J. Addict. 1992; 87: 393–404
  • Chitwood D. D., Inciardi J. A., McBride D. C., McCoy C. B., McCoy H. V., Trapido E. A Community Approach to AIDS Intervention. Greenwood Press, New York 1991
  • Stephens R. C., Feucht T. E., Roman S. W. Effects of an Intervention Program on AIDS-Related Drug and Needle Behavior among Intravenous Drug Users. Am. J. Public Healthy 1991; 81: 568–571
  • Des Jarlais D. C., Friedman S. R., Hopkins W. Risk Reduction for the Acquired Immunodeficiency Syndrome Among Intravenous Drug Users. Ann. Intern. Med. 1985; 103: 755–759
  • UNAIDS/WHO. Report of the Global HIV/AIDS Epidemic. UNAIDS/WHO, Geneva 1998
  • Ball A. L., Rana S., Dehne K. L. HIV Prevention among Injecting Drug Users: Responses in Developing and Transitional Countries. Public Health Rep. 1998; 113: 170–181
  • CDC. HIV/AIDS Surveillance Report. HIV/AIDS 1998; 10: 14
  • Tansey J., O'Riordan T. Cultural Theory and Risk: A Review. Health. Risk Soc. 1999; 1: 71–90
  • Des Jarlais D. C., Casriel C., Friedman S. R., Rosenblum A. AIDS and the Transition to Illicit Drug Injection–Results of a Randomized Trial Prevention Program. Br. J. Addict. 1992; 87: 493–498
  • Naeigus A., Friedman S., Jose B., Goldstein M. F., Curtis R., Ildefonso G., Des Jarlais D. C. High-Risk Personal Networks and Syringe Sharing as Risk Factors for HIV Infection among New Drug Injectors. J. Acquir. Immune Defici. Syndr. Hum. Retrovirol. 1996; 11: 499–509
  • Inciardi J. A., McBride D. C., Surratt L., II. The Heroin Street Addict: Profiling a National Population. Heroin in the Age of Crack Cocaine, J. A. Inciardi, L. D. Harrison. Sage Publications, Thousand Oaks, CA 1998; 31–50
  • Friedman S. R., Des Jarlais D. C., Neaigus A., Abdul-Quader A., Sotheran J. L., Sufian M., Tross S., Goldsmith D. AIDS and the New Drug Injector. Nature 1989; 39: 333–334
  • Erickson K. C., Stull D. D. Doing Team Ethnography. Sage Publications, Thousand Oaks, CA 1998
  • Inciardi J. A., Page J. B. Drug Sharing among Intravenous Drug Users. AIDS 1991; 5: 772–773
  • Martinez R. Freebase Cocaine. Local Drug Abuse: Trends, Patterns, and Issues. National Institute on Drug Abuse, Rockville, MD 1980; 1: 67–70
  • Inciardi J. A., Surratt H. L., Chitwood D. D., McCoy C. B. The Origins of Crack. The American Pipe Dream, J. A. Inciardi, J. E. Rivers, J. A. Inciardi. Harcourt Brace, Fort Worth, TX 1996; 1–14
  • Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse Advance Report; National Institute on Drug Abuse (NIH Publ. # 98-4299). June, 1998
  • Mundell C. Drug Abuse in Washington, DC. Drug Abuse Trends Analysis (DATA) Project. Center for Substance Research, University of Maryland, College Park, MD 1994
  • Ouellet L., Jimenez A. D., Wiebel W. W. Heroin Again: New Users of Heroin in Chicago. School of Public Health, University of Chicago, Chicago 1994
  • Casriel C., Des Jarlais D. C., Rodriguez R., Friedman S. R., Stepherson B., Khuri E. Working with Heroin Sniffers: Clinical Issues in Preventing Drug Injection. J. Subst. Abuse Treat. 1990; 7: 1–10
  • Casriel C., Rockwell R., Stepheson B. Heroin Sniffers: Between Two Worlds. J. Psychoact. Drugs 1988; 20: 437–440
  • Waldorf D. Becoming a Heroin Addict. Anonymous Careers in Dope. Simon & Schuster, Englewood Cliffs, N.J. 1973

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.